Difference between revisions of "QIBA Overview"
Jump to navigation
Jump to search
| Line 10: | Line 10: | ||
| − | For more detail, refer to '''[[Education | + | For more detail, refer to the '''[[Education]]''' page. |
==See Also== | ==See Also== | ||
Revision as of 20:53, 4 May 2016
QIBA is an initiative to advance quantitative imaging and the use of imaging biomarkers in clinical trials and clinical practice by engaging researchers, healthcare professionals and industry . This involves:
- collaborating to identify needs, barriers, and solutions to develop and test consistent, reliable, valid, and achievable quantitative imaging results across imaging platforms, clinical sites, and time.
- accelerating the development and adoption of hardware and software standards needed to achieve accurate and reproducible quantitative results from imaging methods.
QIBA develops Profile specifications and coordinates the necessary research and qualification groundwork.
For more detail, refer to the Education page.
See Also
- QIBA Overview Fact Sheet October 2015
- QIBA Task Force Report August 2011
<link to Projects page> <link to www.rsna.org/qiba and in principle, the website is the formally published location for this content>
Related Activities
- UPICT
- EIBALL
- QIBA Japan
- Pharma Imaging Network for Therapeutics and Diagnostics (PINTAD)